Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Dynarrestin is an inhibitor of dynein 1 and -2.1 It inhibits dynein 1-dependent microtubule gliding (IC50 = 5 µM) and dynein 2-dependent intraflagellar transport in mIMCD-3 inner medullary collecting duct cells when used at concentrations of 0.125 and 1.25 µM. Dynarrestin decreases the number of cells in metaphase, anaphase, or telophase in asynchronous COS-7 cells (IC50 = 6.25 µM). It inhibits the proliferation of primary Ptch+/- murine medulloblastoma cells (IC50 = 0.068 µM) and the expression of GLI1 in KYSE-180 esophageal squamous cell carcinoma cells stimulated with the smoothened (Smo) agonist purmorphamine (Item No. 10009634; IC50 = 0.21 µM).
WARNING This product is not for human or veterinary use.
1. Dynarrestin, a novel inhibitor of cytoplasmic dynein. Cell Chem. Biol. 25(4), 357-369 (2018).